InfuSystem Holdings, Inc. Files 8-K on Financials

Ticker: INFU · Form: 8-K · Filed: Nov 4, 2025 · CIK: 1337013

Infusystem Holdings, INC 8-K Filing Summary
FieldDetail
CompanyInfusystem Holdings, INC (INFU)
Form Type8-K
Filed DateNov 4, 2025
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations

Related Tickers: INFU

TL;DR

InfuSystem Holdings, Inc. (INFU) filed an 8-K on Nov 4, 2025, detailing financial results. Check for updates.

AI Summary

InfuSystem Holdings, Inc. filed an 8-K on November 4, 2025, reporting on its Results of Operations and Financial Condition. The filing details the company's financial status and operational performance as of the reporting date. InfuSystem Holdings, Inc. is incorporated in Delaware and headquartered in Rochester Hills, Michigan.

Why It Matters

This 8-K filing provides investors with crucial updates on InfuSystem Holdings, Inc.'s financial health and operational results, enabling informed investment decisions.

Risk Assessment

Risk Level: low — This is a routine 8-K filing reporting on financial condition and results of operations, which is standard disclosure and does not inherently indicate elevated risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on InfuSystem Holdings, Inc.'s Results of Operations and Financial Condition as of November 4, 2025.

When was this 8-K report filed?

This 8-K report was filed on November 4, 2025.

In which state is InfuSystem Holdings, Inc. incorporated?

InfuSystem Holdings, Inc. is incorporated in Delaware.

What is the principal executive office address for InfuSystem Holdings, Inc.?

The principal executive office address is 3851 West Hamlin Road, Rochester Hills, Michigan 48309.

Has InfuSystem Holdings, Inc. operated under any former company names?

Yes, InfuSystem Holdings, Inc. previously operated under the names HAPC, Inc. and Healthcare Acquisition Partners Corp.

Filing Stats: 527 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-11-04 06:28:54

Filing Documents

02 - Results of Operations and Financial Condition

Item 2.02 - Results of Operations and Financial Condition On November 4, 2025 , InfuSystem Holdings, Inc. (the "Company") issued a press release reporting its financial results for the third quarter of 2025. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 2.02 — "Results of Operations and Financial Condition" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

01 - Financial Statements and Exhibits

Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated November 4 , 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: November 4, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing